Abstract:Background Although epigenetic modifications have been expected to play an important role in neuroplasticity for stroke recovery, the role of dynamic microRNA (miRNA) regulation related to functional outcomes after ischemic stroke remains unclear. Therefore, the current study performed a comprehensive miRNA expression analysis in serum to identify specifically altered circulating miRNAs associated with different grades of functional outcomes in patients with acute ischemic stroke (AIS). Methods Twelve patients with AIS in the middle cerebral artery region were included in this study. Peripheral blood samples were collected from patients one or two days after hospitalization. Total RNA, including small RNAs, was extracted from 400 µL of serum, and comprehensive miRNA expression analysis was performed to identify specifically altered circulating miRNAs associated with different grades of functional outcomes. Functional outcomes were evaluated three months after stroke onset using the modified Rankin Scale (mRS), classified as favorable (mRS score of 0 or 1) or unfavorable (mRS score of 2 to 5). Differentially expressed miRNAs were analyzed using the DESeq2 package. Target genes of the miRNAs were explored using miRTargetLink 2.0. Results Acute miRNA expression dynamics were characterized by differences in the patients' functional outcomes following ischemic stroke. The favorable outcome group exhibited significantly downregulated miRNAs, including hsa-miR-218-1, hsa-miR-218-2, hsa-miR-320e, hsa-miR-320d-1, hsa-miR-320d-2, hsa-miR-326, and hsa-miR-4429. In addition, 15 miRNAs, including hsa-miR-223, hsa-miR-18a, hsa-miR-411, and hsa-miR-128-1, were significantly upregulated in the favorable outcome group compared to the unfavorable outcome group. Interesting and strong validated networks between miRNAs and their target genes were identified. Conclusion This study identified specifically altered circulating miRNAs in serum associated with varying grades of functional outcomes in AIS patients and explored miRNA-target gene networks that might contribute to these outcomes. Although further studies are needed, this study highlights their potential role as biomarkers for predicting functional outcomes in patients with AIS.

Progress of Studies Relevant to the Roles of Micro Ribonucleic Acids in Ischemic Stroke

Research Progress of Micro Ribonucleic Acid in Cerebral Ischemia

Micro-Ribonucleic Acid and Ischemic Stroke

MicroRNAs and stroke:a brief summary of recent research progress

MicroRNAs and stroke

The Roles of MicroRNAs in Stroke: Possible Therapeutic Targets

MicroRNAs Expression and Function in Cerebral Ischemia Reperfusion Injury

Advances in Research on Micrornas and Ischemic Stroke

Micrornas: Innovative Targets for Cerebral Ischemia and Stroke

MicroRNAs in Cerebral Ischemia.

Diagnostic Performance of Circulating MicroRNAs in Acute Ischemic Stroke

MicroRNA in ischemic stroke etiology and pathology

MicroRNA: An Emerging Predictive, Diagnostic, Prognostic and Therapeutic Strategy in Ischaemic Stroke

Considering Context-Specific microRNAs in Ischemic Stroke with Three "W": Where, When, and What

MicroRNAs Modulate Neuroinflammation after Intracerebral Hemorrhage: Prospects for New Therapy.

Diagnostic Performance of Circulating MicroRNAs in Acute Ischemic Stroke A Protocol for Systematic Review and Meta-Analysis

Characterization of Dysregulated miRNA in Peripheral Blood Mononuclear Cells from Ischemic Stroke Patients

Unveiling the Regulatory Role of miRNAs in Stroke Pathophysiology and Diagnosis

Identifying the regulatory network of microRNAs and mRNAs to clarify molecular mechanisms in stroke by bioinformatics analysis

Bioinformatic Exploration of Circulating microRNAs Related to Functional Outcomes in Patients With Acute Ischemic Stroke: An Exploratory Prospective Study

Bioinformatics Method Combined with Logistic Regression Analysis Reveal Potentially Important Mirnas in Ischemic Stroke.